Effects of fermented milk peptides supplement on blood pressure and vascular function in spontaneously hypertensive rats

Food Science and Biotechnology

Volumn 19, Issue 5, 2010, Pages 1409-1413

  Kim, Sung Min ^a   Park, Soojin ^b   Choue, Ryowon ^a  

^a Kyung Hee University   (South Korea)

^b Semyung University   (South Korea)

Author keywords

Angiotensin converting enzyme; Aortic thickness; Blood pressure; Fermented milk peptide; Hypertension

Indexed keywords

RATTUS;

EID: 79957632287     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10068-010-0201-0     Document Type: Note

References (29)

1. Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A. The kallikrein-kinin system: Current and future pharmacological targets. J. Pharm. Sci. 99: 6-38 (2005)
2. Miyazaki M, Takai S. Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase. J. Pharm. Sci. 100: 391-397 (2006)
3. Mitchell GF, Dunlap ME, Warnica W, Ducharme A, Arnold JM, Tardif JC, Solomon SD, Domanski MJ, Jablonski KA, Rice MM, Pfeffer MA. Long-term trandolapril treatment is associated with reduced aortic stiffness: The prevention of events with angiotensinconverting enzyme inhibition hemodynamic substudy. Hypertension 49: 1271-1277 (2007)
4. Akiba Y, Yamaguchi N, Amano H, Fujii T. Role of nitric oxide in the control of blood pressure in young and adult spontaneously hypertensive rats. Clin. Exp. Pharmacol. P. 22: 142-143 (1995)
5. Trachtman H, Futterweit S, Singhal P. Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem. Bioph. Res. Co. 207: 120-125 (1995)
6. Cruzado M, Castro C, Risler N, Miatello R. Changes of inducible nitric oxide synthase in aortic cells during the development of hypertension: Effect of angiotensin II. Biocell 26: 61-67 (2002)
7. Israili Z, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann. Intern. Med. 117: 234-242 (1992)
8. Webster J, Koch HF. Aspects of tolerability of centrally acting antihypertensive drugs. J. Cardiovasc. Pharm. 3: 49-54 (1996)
9. Möller NP, Scholz-Ahrens KE, Roos N, Schrezenmeir J. Bioactive peptides and proteins from foods: Indication for health effects. Eur. J. Nutr. 47: 171-182 (2008)
10. Kohama Y, Oka H, Kayamori Y, Tsujikawa K, Mimura T, Nagase Y, Satake M. Potent synthetic analogues of angiotensin-converting enzyme inhibitors derived from tuna muscle. Agr. Biol. Chem. Tokyo 55: 2169-2170 (1991)
11. Seppo L, Jauhiainen T, Poussa T, Korpela R. A fermented milk high in bioactive peptides has a blood pressure lowering effect in hypertensive subjects. Am. J. Clin. Nutr. 77: 326-330 (2003)
12. Gouda KGM, Gowda LR, Rao AG, Prakash V. Angiotensin Iconverting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max). J. Agr. Food Chem. 54: 4568-4573 (2006)
13. Majumder K, Wu J. Angiotensin I converting enzyme inhibitory peptides from simulated in vitro gastrointestinal digestion of cooked eggs. J. Agr. Food Chem. 57: 471-477 (2009)
14. Jimsheena VK, Gowda LR. Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: Structureactivity relationship. Peptides 316: 1165-1176 (2010)
15. Masuda O, Nakamura Y, Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J. Nutr. 126: 1363-1368 (1996)
16. Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Tanaka T. Purification and characterization of angiotensin Iconverting enzyme inhibitors from sour milk. J. Dairy Sci. 78: 777-783 (1995)
17. Hata Y, Yamamoto M, Ohni M. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am. J. Clin. Nutr. 64: 767-771 (1996)
18. Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J. Am. Coll. Nutr. 24: 257-265 (2005)
19. Swislocki ALM, Kinney LaPier TL, Khuu DT, Fann KY, Tait M, Rodnick KJ. Metabolic, hemodynamic, and cardiac effects of captopril in young, spontaneously hypertensive rats. Am. J. Hypertens. 12: 581-589 (1999)
20. Jang A, Cho YJ, Lee JI, Shin JH, Kim IS, Lee M. The effect of beef peptide on blood pressure and serum lipid concentration of spontaneously hypertensive rat. J. Anim. Sci. Technol. 46: 107-114 (2004)
21. Das ML, Soffer RS. Pulmonary angiotensin-converting enzyme. J. Biol. Chem. 250: 6762-6768 (1975)
22. Cushman DW, Cheng HS. Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung. Biochem. Pharmacol. 20: 1637-1648 (1971)
23. Leila MM, Daniele G, Carlos A. Aortic wall remodeling in rats with nitric oxide deficiency treated by enalapril or verapamil. Pathol. Res. Pract. 200: 211-217 (2004)
24. Penny M, Kris-Etherton, Jessica AG, Kirsten FH, Sheila GW. Milk products, dietary patterns, and blood pressure management. J. Am. Coll. Nutr. 28: 103s-119s (2009)
25. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J. Clin. Invest. 97: 1916-1923 (1996)
26. Romero JC, Reckelhoff JF. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 34: 943-949 (1999)
27. Szabo C, Ischiropoulos H, Radi R. Peroxynitrite: Biochemistry, pathophysiology, and development of therapeutics. Nat. Rev. Drug Discov. 6: 662-680 (2007)
28. Matsumoto K, Hayashi K. Stress and strain distribution in hypertensive and normotensive rat aorta considering residual strain. J. Biomech. Eng. 118: 62-73 (1996)
29. Heeneman S, Sluimer JC, Daemen MJ. Angiotensin-converting enzyme and vascular remodeling. Circ. Res. 101: 441-454 (2007)